Publication|Articles|April 18, 2025
- Pharmaceutical Executive: April 2025
- Volume 45
- Issue 3
Pharmaceutical Executive: April 2025 Interactive Digital Edition
View the Pharmaceutical Executive April 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
over 1 year ago
‘Earning’ Powerover 1 year ago
Milan Kalawadia: Carving Out New Pathwaysover 1 year ago
Bringing Biotech Innovation Across Bordersover 1 year ago
Using AI to Predict Launch Successover 1 year ago
Improving Your Earned Media Strategy: Tips and Insightsover 1 year ago
The Future of DTC in Pharmaover 1 year ago
Translating ‘Digital-First’ to Commercial Successover 1 year ago
HEOR: From Proving Product Value to Proving Its Own WorthAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
2026 Pharm Exec Top 50 Companies
2
M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351
3
Who Pays for Tariff Driven Input Cost Increases?
4
Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs
5